Report Title | Price | Action |
---|---|---|
Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) - Drugs in Development, 2021
Neurogenic Locus Notch Homolog Protein 1 (Translocation Associated Notch Protein TAN 1 or NOTCH1) - Drugs in Development, 2021 Summary Neurogenic Lo...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021
Tyrosine Protein Kinase Receptor UFO (AXL Oncogene or AXL or EC 2.7.10.1) - Drugs in Development, 2021 Summary Tyrosine Protein Kinase Receptor UFO ...
Published: Apr-2021 | No. of Pages: 75
|
$ 3000 | |
Wilms' Tumor (Nephroblastoma) (Oncology) - Drugs in Development, 2021
Wilms' Tumor (Nephroblastoma) (Oncology) - Drugs in Development, 2021 Summary Wilms' Tumor (Nephroblastoma) (Oncology) - Drugs in Development, 2021 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021
Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Muscle Injury (Musculoskeletal Disorders) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Respiratory Tract Inflammatory Disorders (Respiratory) - Drugs in Development, 2021
Respiratory Tract Inflammatory Disorders (Respiratory) - Drugs in Development, 2021 Summary Respiratory Tract Inflammatory Disorders (Respiratory) -...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
Hyperphosphatemia (Nutritional Disorders) - Drugs in Development, 2021
Hyperphosphatemia (Nutritional Disorders) - Drugs in Development, 2021 Summary Hyperphosphatemia (Nutritional Disorders) - Drugs in Development, 202...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Cells Expressing Nectin 4 (Ig Superfamily Receptor LNIR or Poliovirus Receptor Related Protein 4 or Nectin Cell Adhesion Molecule 4 or PVRL4 or NECTIN4) - Drugs in Development, 2021
Cells Expressing Nectin 4 (Ig Superfamily Receptor LNIR or Poliovirus Receptor Related Protein 4 or Nectin Cell Adhesion Molecule 4 or PVRL4 or NECTIN...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - Drugs in Development, 2021
Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - Drugs in Development, 2021 Summary Nicotinamide N Methyltransferase (NNMT or EC 2.1.1.1) - D...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Drugs in Development, 2021
Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Drugs in Development, 2021 Summary Focal Adhesion Kinase (FAK or EC 2.7.10.2) - Drugs in Development, 2...
Published: Apr-2021 | No. of Pages: 45
|
$ 3000 | |
Myopia (Ophthalmology) - Drugs in Development, 2021
Myopia (Ophthalmology) - Drugs in Development, 2021 Summary Myopia (Ophthalmology) - Drugs in Development, 2021 provides an overview of the Myopia p...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021
Muscle Wasting Disorders (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Muscle Wasting Disorders (Musculoskeletal Disorders) - Dru...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Retinal Degeneration (Ophthalmology) - Drugs in Development, 2021
Retinal Degeneration (Ophthalmology) - Drugs in Development, 2021 Summary Retinal Degeneration (Ophthalmology) - Drugs in Development, 2021 provides...
Published: Apr-2021 | No. of Pages: 50
|
$ 2000 | |
Hypertrophic Scars (Dermatology) - Drugs in Development, 2021
Hypertrophic Scars (Dermatology) - Drugs in Development, 2021 Summary Hypertrophic Scars (Dermatology) - Drugs in Development, 2021 provides an over...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs in Development, 2021
Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs in Development, 2021 Summary Cells Expressing Prostate Stem Cell Antigen (PSCA) - Drugs i...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) - Drugs in Development, 2021
Nuclear Receptor Subfamily 2 Group F Member 6 (V erba Related Protein 2 or NR2F6) - Drugs in Development, 2021 Summary Nuclear Receptor Subfamily 2 ...
Published: Apr-2021 | No. of Pages: 35
|
$ 3000 | |
Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or EC 2.7.10.1) - Drugs in Development, 2021
Receptor Tyrosine Protein Kinase ERBB 3 (Proto Oncogene Like Protein c ErbB 3 or Tyrosine Kinase Type Cell Surface Receptor HER3 or HER3 or ERBB3 or E...
Published: Apr-2021 | No. of Pages: 60
|
$ 3000 | |
Viral Respiratory Tract Infection (Respiratory) - Drugs in Development, 2021
Viral Respiratory Tract Infection (Respiratory) - Drugs in Development, 2021 Summary Viral Respiratory Tract Infection (Respiratory) - Drugs in Deve...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 | |
Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021
Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Androgen-Sensitive Prostate Cancer (Oncology) - Drugs in Developm...
Published: Apr-2021 | No. of Pages: 30
|
$ 2000 | |
Retinopathy (Ophthalmology) - Drugs in Development, 2021
Retinopathy (Ophthalmology) - Drugs in Development, 2021 Summary Retinopathy (Ophthalmology) - Drugs in Development, 2021 provides an overview of th...
Published: Apr-2021 | No. of Pages: 40
|
$ 2000 | |
Hypoxia (Respiratory) - Drugs in Development, 2021
Hypoxia (Respiratory) - Drugs in Development, 2021 Summary Hypoxia (Respiratory) - Drugs in Development, 2021 provides an overview of the Hypoxia pi...
Published: Apr-2021 | No. of Pages: 35
|
$ 2000 |